gsk glp 1 agonist Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1: Cell Metabolism Emerging Trends in the Development

Biomed Pharmacother Biomedecine Pharmacother

GIP receptor agonism attenuates GLP-1 receptor Agonist-Induced nausea and Emesis in preclinical models

Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence

Trial data showed that Saxenda , in combination with a reduced-calorie diet and increased physical activity, resulted in significantly greater weight loss in some patients than reduced-calorie diet and physical activity alone

Preclinical studies have demonstrated that GLP-1 receptor agonists reduce neuroinflammation, reduce tau phosphorylation, reduce amyloid deposition, increase synaptic function, and improve memory formation

Haney, M